Editorial
Is there any role left for p210-derived peptide vaccines in chronic myeloid leukemia?
- PMID: 12091115
Item in Clipboard
Editorial
Is there any role left for p210-derived peptide vaccines in chronic myeloid leukemia?
Haematologica.
2002 Jul.
No abstract available
Comment on
-
Antitumor vaccination: where we stand.Haematologica. 2000 Nov;85(11):1172-206. Haematologica. 2000. PMID: 11074658 Review.
Similar articles
-
Chaperone-rich cell lysate embedded with BCR-ABL peptide demonstrates enhanced anti-tumor activity against a murine BCR-ABL positive leukemia.FASEB J. 2007 Jul;21(9):2173-84. doi: 10.1096/fj.06-7843com. Epub 2007 Feb 27. FASEB J. 2007. PMID: 17327358
-
CML vaccines as a paradigm of the specific immunotherapy of cancer.Blood Rev. 2000 Jun;14(2):111-20. doi: 10.1054/blre.2000.0127. Blood Rev. 2000. PMID: 11012250 Review.
-
Chronic myeloid leukemia-specific T-cell responses.Haematologica. 2004 Sep;89(9):1035-6. Haematologica. 2004. PMID: 15377462 No abstract available.
-
Definition of immunogenic antigens in chronic myeloid leukemia (CML) towards the development of cancer vaccines.Leuk Res. 2005 Dec;29(12):1367-9. doi: 10.1016/j.leukres.2005.06.022. Epub 2005 Aug 30. Leuk Res. 2005. PMID: 16135383 No abstract available.
-
Vaccination for leukemia.Biol Blood Marrow Transplant. 2006 Jan;12(1 Suppl 1):13-8. doi: 10.1016/j.bbmt.2005.10.014. Biol Blood Marrow Transplant. 2006. PMID: 16399579 Review.
Cited by
-
Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome.Blood. 2005 Aug 1;106(3):841-51. doi: 10.1182/blood-2004-05-2017. Epub 2005 Apr 12. Blood. 2005. PMID: 15827127 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical